RNase III nucleases from diverse kingdoms serve as antiviral effectors
Lauren C. Aguado,
Sonja Schmid,
Jared May,
Leah R. Sabin,
Maryline Panis,
Daniel Blanco-Melo,
Jaehee V. Shim,
David Sachs,
Sara Cherry,
Anne E. Simon,
Jean-Pierre Levraud and
Benjamin R. tenOever ()
Additional contact information
Lauren C. Aguado: Icahn School of Medicine at Mount Sinai
Sonja Schmid: Icahn School of Medicine at Mount Sinai
Jared May: University of Maryland College Park
Leah R. Sabin: University of Pennsylvania
Maryline Panis: Icahn School of Medicine at Mount Sinai
Daniel Blanco-Melo: Icahn School of Medicine at Mount Sinai
Jaehee V. Shim: Icahn School of Medicine at Mount Sinai
David Sachs: Icahn School of Medicine at Mount Sinai
Sara Cherry: University of Pennsylvania
Anne E. Simon: University of Maryland College Park
Jean-Pierre Levraud: Macrophages et Développement de l’Immunité, Institut Pasteur, CNRS UMR3738
Benjamin R. tenOever: Icahn School of Medicine at Mount Sinai
Nature, 2017, vol. 547, issue 7661, 114-117
Abstract:
RNase III from all three domains of life elicits RNA-targeting antiviral activity that is independent of, and possibly predates, other known eukaryotic antiviral systems.
Date: 2017
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/nature22990 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:547:y:2017:i:7661:d:10.1038_nature22990
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/nature22990
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().